Navigation Links
Opening Dedication of the New John G. Rangos Sr. Research Center at the New Children's Hospital of Pittsburgh of UPMC Campus in Lawrenceville
Date:10/29/2008

Research building marks the first completed phase of the new Children's Hospital campus

PITTSBURGH, Oct. 29 /PRNewswire/ -- Children's Hospital of Pittsburgh of UPMC officially opened its new 10-story, state-of-the-art John G. Rangos Sr. Research Center today marking the first completed phase of its new premier pediatric campus.

With more than 300,000 square feet of space, the new center will serve as the hub of pediatric health research for the region. The center - double the size of the current location - will enhance the hospital's ability to recruit top researchers from around the world.

Research is fundamental to Children's Hospital's mission, one that ties clinical care to both research and education.

The new facility will support biomedical research, including pediatric cancer, diabetes, heart disease, liver failure, childhood infection and inflammatory diseases, genomics, immunology and neuroscience, among other fields. The new flexible lab space can accommodate 70 principal investigators.

"The flexible open lab design facilitates the kind of collaborative interaction between investigators and laboratory groups that is necessary for major research advances in the 21st century. It also permits sharing of equipment to drive down the cost of research," said David H. Perlmutter, MD, physician-in-chief and scientific director, Children's Hospital, and the Vira I. Heinz Professor and chair of the Department of Pediatrics, University of Pittsburgh School of Medicine. This research building will serve as the hub for Children's Hospital, UPMC and the University of Pittsburgh to advance the cause of child health through cutting-edge research.

Children's Hospital's research heritage includes contributions to medical science dating back to Jonas Salk's historic polio vaccine.

"Dr. Perlmutter has transformed the research program at Children's Hospital into one of the fastest growing pediatric research programs in th
'/>"/>

SOURCE Children?s Hospital of Pittsburgh of UPMC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island
2. ACIST Medical Systems Announces the Opening of Its New Expanded Corporate Headquarters in Eden Prairie, MN
3. Pharmatek Announces Official Opening of New Highly-Potent & Cytotoxic Development and Manufacturing Facility
4. Abingdon Life Sciences, Inc. Announces Opening of Office in Carlsbad, Ca.
5. Pinnacle Biologics Announces Opening of Executive Offices in Bannockburn, Illinois and the Addition of Sandra Miller to the Board of Directors
6. Environmental Power Announces Opening of New Corporate Headquarters in Tarrytown, NY
7. Finesse Solutions Expands by Opening Sales and Service Centers
8. UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
9. Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
10. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
11. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... 3 JourneyLite of Houston, LLC announced ... patients a second surgical option, vertical sleeve gastrectomy ... it currently performs. The first sleeve gastrectomy procedure at ... St. Laurent, MD on October 20, 2009. The ...
(Date:12/3/2009)... ACCESS PHARMACEUTICALS, INC. ... on its European commercial launch of MuGard, an FDA ... of radiation treatment and chemotherapy. MuGard is commercially launched ... the UK, Germany, Italy, Norway, Greece and Sweden. Access ...
(Date:12/3/2009)... Shire plc (LSE: SHP, Nasdaq: SHPGY ), the ... of five lots and voluntary market withdrawal of one ... . Shire is taking this action because some Daytrana ... not meet their release liner removal specification, and as ...
(Date:12/3/2009)... Inc. (NYSE: IMA ), a global leader in ... through the merger of rapid diagnostics and health management, has ... B Convertible Perpetual Preferred Stock ( IMA-PB). The dividend will ... amount per share equal to the quotient of (a) $3.00 ...
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5
... LEUVEN, Belgium, August 28 , - Professor ... Board and,Scientific Advisor, ThromboGenics NV (Euronext Brussels: ... eye disease, vascular disease and cancer,announces today that ... been appointed to succeed Professor Desire Collen as ...
... ENGLEWOOD, Colo., Aug. 28 Inc.com has again included,Baxa ... private,companies in the country. Baxa ranked number 4,611 and ... list. The company has grown steadily,since its founding in ... Colorado headquarters and UK subsidiary offices., "The Inc ...
... SAN FRANCISCO, Aug. 28 Medivation, Inc.,(Nasdaq: MDVN ... chief,executive officer, will present at the following conferences:, ... 4, at 9:00 a.m. Eastern Time at the Millennium ... Life Sciences Conference on Wednesday, September 24,at 4:30 p.m. ...
Other Biology Technology:ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer 2ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer 3ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer 4Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US 2Medivation Announces Participation in Upcoming Conferences 2
(Date:12/4/2009)... organs relevant for coronary artery disease (CAD), scientists at ... module of genes that is important for the recruitment ... findings, which are to be published in the open-access ... migration of white blood cells in the development of ...
(Date:12/4/2009)... used by physicians and scientists to study brain function ... largely unknown whether the electrodes on the head give ... brain. Scientists at the Max Planck Institute for Biological ... link between the activity generated within the brain to ...
(Date:12/4/2009)... Using a new mathematical model of heart cells, University ... critical enzyme, calmodulin kinase II (CaM kinase), disrupts the ... study, which also involved Columbia University, was published online ... . , "Recently, researchers have developed great interest ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2How to read brain activity? 2U-Iowa study helps advance heart-related research 2Arctic climate under greenhouse conditions in the Late Cretaceous 9187 1Arctic climate under greenhouse conditions in the Late Cretaceous 9187 2Arctic climate under greenhouse conditions in the Late Cretaceous 9187 3European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 1European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 2Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday July 23 2009 51200 1
... shortening of telomeres, the protective "caps" at the end of ... physical decline. Once they are gone, so are we. But ... Researchers at Salk Institute for Biological Studies demonstrate for the ... trials of old age although its telomeres are still long, ...
... world's vaccine manufacturers will be in a race against ... new technique to more efficiently produce the disarmed viruses ... in large quantities, life-saving inoculations may be available more ... governments worldwide prepare for a predicted pandemic of avian ...
... immune mechanisms kick in to fight them off. The ... protein called HIF-1 alpha regulates this. Interestingly, the cells ... this low-oxygen environment. In a new study appearing in ... Clinical Investigation, Randall Johnson and collegues from UCSD show ...
Other Biology News:Tiny roundworm's telomeres help scientists to tease apart different types of aging 2Tiny roundworm's telomeres help scientists to tease apart different types of aging 3UW scientists report a new method to speed bird flu vaccine production 2UW scientists report a new method to speed bird flu vaccine production 3
...
Human Presenilin-2 NTF Affinity Purified Polyclonal Ab...
2'-Fluorine-CTP (2'-F-CTP) is readily incorporated into transcripts by T7 and SP6 R&DNA™ Polymerase and is available separately....
Human Glypican 2 Biotinylated Affinity Purified PAb...
Biology Products: